We are live on ! Find out more
B

Bailard Portfolio holdings

AUM $4.35B
1-Year Est. Return 23.57%
This Fund
S&P 500
This Quarter Est. Return
+5.01%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$1.71B
AUM Growth
+$31.6M
Cap. Flow
-$34.4M
Cap. Flow %
-2.01%
Top 10 Hldgs %
32.57%
Holding
586
New
76
Increased
162
Reduced
181
Closed
60

Sector Composition

Rank Sector Weight
1 Technology 15.28%
2 Healthcare 6.75%
3 Financials 6.23%
4 Communication Services 5.69%
5 Industrials 4.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAI
576
DELISTED
CAI International, Inc.
CAI
-11,600
Closed -$270K
JAX
577
DELISTED
J. Alexander's Holdings, Inc.
JAX
-21,031
Closed -$234K
IMMU
578
PUT
DELISTED
Immunomedics Inc
IMMU
-53,500
Closed -$134K
AXAS
579
DELISTED
Abraxas Petroleum Corp
AXAS
-10,435
Closed -$603K
WUBA
580
DELISTED
58.com Inc
WUBA
-6,000
Closed -$416K
DERM
581
PUT
DELISTED
Dermira, Inc.
DERM
-108,000
Closed -$22K
UCFC
582
DELISTED
United Community Financial Corp
UCFC
-47,000
Closed -$517K
ONCE
583
PUT
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
-33,000
Closed -$123K
PES
584
DELISTED
Pioneer Energy Services Corp.
PES
-96,700
Closed -$566K
KND
585
DELISTED
Kindred Healthcare
KND
-70,000
Closed -$630K
ZGNX
586
PUT
DELISTED
Zogenix, Inc.
ZGNX
-103,000
Closed -$535K

Similar funds

Bailard's Q3 2018 Portfolio in Review

As of Q3 2018, Bailard held 586 positions worth $1.71B, up 1.9% from $1.68B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Bailard's Q3 2018 filing shows 76 new, 162 increased, 181 reduced and 60 closed positions. Its largest new stake was Teva Pharmaceuticals: 369,700 shares worth $7.96M. The largest sale was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, an estimated $58.9M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

  • Bailard's largest Q3 2018 buy was Teva Pharmaceuticals: 369,700 shares worth $7.96M.
  • Bailard added most to iShares Russell 2000 Value ETF in Q3 2018, an estimated $58.4M increase.
  • Bailard's biggest Q3 2018 reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, cutting an estimated $58.9M.
  • Bailard fully exited Mercado Libre in Q3 2018, selling an estimated $3.89M.
  • Bailard's ten largest holdings make up 33% of its $1.71B portfolio in Q3 2018.
  • Bailard opened 76 new positions and closed 60 in Q3 2018.
  • Bailard's portfolio value rose 1.9% quarter-over-quarter to $1.71B.

Based on Bailard's 13F filing for Q3 2018, filed 13 Nov 2018.